SERPINB5 over-expression has been shown to promote metastasis in pancreatic ductal adenocarcinoma, and knockdown of SERPINB5 reduced the primary tumor weight and significantly decreased the amount of metastasis [24]. Here, SERPINB5 is linked to pancreatic ductal adenocarcinoma.